DVA
DaVita Inc

2,203
Loading...
Loading...
News
all
press releases
Zacks Industry Outlook Highlights Quest Diagnostics, DaVita, Addus HomeCare and The Pennant
Quest Diagnostics, DaVita, Addus HomeCare, and The Pennant Group are positioned to benefit from telehealth, AI adoption, and rising demand in the $747B home healthcare market.
Zacks·2d ago
News Placeholder
More News
News Placeholder
4 Outpatient Home Health Stocks Worth Watching Amid Shifting Trends
An aging global population and AI dominance are likely to drive the Zacks Medical - Outpatient and Home Healthcare industry despite the macroeconomic challenges. DGX, DVA, ADUS and PNTG are well-poised to gain.
Zacks·3d ago
News Placeholder
DaVita HealthCare (DVA) Gains As Market Dips: What You Should Know
The latest trading day saw DaVita HealthCare (DVA) settling at $132.83, representing a +1.28% change from its previous close.
Zacks·4d ago
News Placeholder
Should Value Investors Buy DaVita (DVA) Stock?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Zacks·5d ago
News Placeholder
DaVita HealthCare (DVA) Sees a More Significant Dip Than Broader Market: Some Facts to Know
In the latest trading session, DaVita HealthCare (DVA) closed at $128, marking a -1.62% move from the previous day.
Zacks·10d ago
News Placeholder
Why DaVita HealthCare (DVA) is a Top Growth Stock for the Long-Term
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Zacks·10d ago
News Placeholder
DaVita HealthCare (DVA) Stock Drops Despite Market Gains: Important Facts to Note
DaVita HealthCare (DVA) closed at $132.26 in the latest trading session, marking a -3.26% move from the prior day.
Zacks·17d ago
News Placeholder
Should Value Investors Buy DaVita (DVA) Stock?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Zacks·25d ago
News Placeholder
DaVita Under Fire After Cyberattack Compromises 2.7 Million Patients’ Information
The dialysis provider said care at its nearly 3,000 clinics and at-home programs continued without interruption, though the attack caused temporary disruptions and $13.5 million in added costs.
Stocktwits·1mo ago
News Placeholder
Cardinal Health to Acquire Solaris Health for Urology Expansion
CAH is set to buy Solaris Health for $2.4B, boosting urology presence with 750+ providers and expanding Specialty Alliance reach.
Zacks·1mo ago

Latest DVA News

View

Advertisement|Remove ads.

Advertisement|Remove ads.